XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.95
+6.21%Forward multiples
Based on analyst estimates
- P/E forward
- 44.79x
- P/E 2026E
- —
- P/E 2027E
- 32.92x
- P/E 2028E
- 19.79x
- P/S forward
- 4.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -205.10x
- Price / sales
- 5.95x
- Price / cash flow
- 35.27x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 6.45x
- EV / EBITDA
- 130.45x
- EV / EBIT
- 59.14x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026